Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,045 | 53 | 97.2% |
| Education | $29.99 | 1 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $182.68 | 10 | $0 (2024) |
| Amgen Inc. | $170.26 | 12 | $0 (2024) |
| PFIZER INC. | $93.09 | 1 | $0 (2017) |
| ABBVIE INC. | $80.41 | 5 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $78.66 | 1 | $0 (2017) |
| Abbott Laboratories | $56.22 | 1 | $0 (2018) |
| Exact Sciences Corporation | $53.77 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $48.93 | 3 | $0 (2022) |
| Lilly USA, LLC | $48.04 | 3 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $46.61 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $326.61 | 19 | AstraZeneca Pharmaceuticals LP ($168.16) |
| 2023 | $225.94 | 14 | Amgen Inc. ($65.99) |
| 2022 | $76.34 | 5 | ABBVIE INC. ($18.03) |
| 2021 | $33.40 | 2 | Lilly USA, LLC ($33.40) |
| 2020 | $33.64 | 2 | GlaxoSmithKline, LLC. ($18.64) |
| 2019 | $23.25 | 2 | Amgen Inc. ($23.25) |
| 2018 | $112.98 | 4 | Abbott Laboratories ($56.22) |
| 2017 | $242.72 | 6 | PFIZER INC. ($93.09) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: DIABETES | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Respiratory | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/03/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Cardio-renal | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Respiratory | ||||||
| 05/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Oncology | ||||||
| 04/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Gastroenterology | ||||||
| 03/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), FARXIGA | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: Respiratory | ||||||
| 02/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Inflammation | ||||||
| 01/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Respiratory | ||||||
| 11/30/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Gastroenterology | ||||||
| 08/30/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.08 | General |
| 08/23/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Oncology | ||||||
| 08/02/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Biological | ||||||
| 07/12/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 177 | 217 | $48,034 | $14,276 |
| 2021 | 12 | 575 | 970 | $188,119 | $78,556 |
| 2020 | 11 | 634 | 1,166 | $199,055 | $75,380 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 139 | $31,553 | $7,549 | 23.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 33 | 33 | $6,798 | $4,173 | 61.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 16 | $5,072 | $1,578 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 29 | $4,611 | $975.63 | 21.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 173 | 500 | $113,500 | $41,728 | 36.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 98 | 98 | $20,188 | $12,476 | 61.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 49 | 58 | $18,386 | $7,532 | 41.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 118 | $18,762 | $6,921 | 36.9% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 44 | 44 | $4,620 | $2,923 | 63.3% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 14 | 14 | $4,256 | $2,250 | 52.9% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 14 | 14 | $2,296 | $1,757 | 76.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 11 | 11 | $3,399 | $1,620 | 47.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 52 | 52 | $1,404 | $817.96 | 58.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 15 | 16 | $432.00 | $251.73 | 58.3% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 11 | 12 | $480.00 | $204.96 | 42.7% |
| 81003 | Automated urinalysis test | Office | 2021 | 23 | 33 | $396.00 | $74.25 | 18.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 181 | 642 | $129,684 | $43,377 | 33.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 127 | 127 | $26,162 | $13,931 | 53.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 81 | 145 | $19,865 | $6,623 | 33.3% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 20 | 22 | $6,688 | $3,125 | 46.7% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 24 | 24 | $3,936 | $2,399 | 60.9% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 33 | 33 | $3,465 | $1,923 | 55.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 18 | 19 | $5,187 | $1,830 | 35.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 68 | 68 | $1,836 | $1,073 | 58.4% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 35 | 35 | $1,260 | $664.79 | 52.8% |
About Dr. Lauren Mitchell, D.O
Dr. Lauren Mitchell, D.O is a Family Medicine healthcare provider based in Miami, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2015. The National Provider Identifier (NPI) number assigned to this provider is 1952785537.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lauren Mitchell, D.O has received a total of $1,075 in payments from pharmaceutical and medical device companies, with $326.61 received in 2024. These payments were reported across 54 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,045).
As a Medicare-enrolled provider, Mitchell has provided services to 1,386 Medicare beneficiaries, totaling 2,353 services with total Medicare billing of $168,211. Data is available for 3 years (2020–2022), covering 27 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Miami, OK
- Active Since 07/14/2015
- Last Updated 06/27/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1952785537
Products in Payments
- AIRSUPRA (Drug) $110.47
- ELIQUIS (Drug) $93.09
- BELSOMRA (Drug) $78.66
- Otezla (Drug) $77.38
- FARXIGA (Drug) $72.21
- Connectivity and Remote care (Device) $56.22
- Cologuard Collection Kit (Device) $53.77
- QULIPTA (Drug) $51.46
- Prolia (Biological) $49.38
- XIFAXAN (Drug) $46.61
- TRELEGY ELLIPTA (Drug) $34.98
- EMGALITY (Drug) $33.40
- EVENITY (Biological) $31.08
- VRAYLAR (Drug) $29.99
- UBRELVY (Drug) $28.95
- REXULTI (Drug) $18.80
- NURTEC ODT (Drug) $16.97
- Rybelsus (Drug) $16.27
- Veozah (Drug) $15.16
- ENTRESTO (Drug) $14.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Miami
Keila Hoover, M.d, M.D
Family Medicine — Payments: $1.1M
Dr. Yamirka Duardo-Guerra, M.d, M.D
Family Medicine — Payments: $1.0M
Ramon Leon, Md, MD
Family Medicine — Payments: $179,798
Mirel Sanchez, M.d, M.D
Family Medicine — Payments: $165,828
Gilberto Seco, Md, MD
Family Medicine — Payments: $127,612
Dr. Clifford Kinder, Md, MD
Family Medicine — Payments: $121,261